Opinion: The 340B drug-pricing program, a critical MetroHealth patient lifeline, is under threat
Posted on May 20, 2022 |
“This spring, I find myself embracing the change of season and reflecting on the challenges of seasons past. For two years, we intensive-care professionals have cared for critically ill COVID-19 ...